English
日本語
简体中文
繁體中文
한국어
✖
Menu
RCSB PDB
PDBe
BMRB
Adv. Search
Search help
Search by PDB author
6Q6O
RORCVAR2 (RORGT, 264-499) IN COMPLEX WITH COMPOUND 2 AT 2.3A: Identification of N-aryl imidazoles as potent and selective RORgt inhibitors
Descriptor:
CHOLIC ACID, Nuclear receptor ROR-gamma, propan-2-yl (2~{S})-2-[[2,6-bis(chloranyl)phenyl]-(furan-2-ylcarbonyl)amino]propanoate
Authors:
Kallen, J.
Deposit date:
2018-12-11
Release date:
2019-11-27
Last modified:
2024-01-24
Method:
X-RAY DIFFRACTION (2.3 Å)
Cite:
Structure-Based and Property-Driven Optimization ofN-Aryl Imidazoles toward Potent and Selective Oral ROR gamma t Inhibitors.
J.Med.Chem., 62, 2019
6Q7H
RORCVAR2 (RORGT, 264-499) IN COMPLEX WITH COMPOUND 9 AT 2.3A: Identification of N-aryl imidazoles as potent and selective RORgt inhibitors
Descriptor:
1-[2,4-bis(chloranyl)-3-[2-(5-chloranylfuran-2-yl)-5-methyl-4-(trifluoromethyl)imidazol-1-yl]phenyl]azetidine-3-carboxylic acid, Nuclear receptor ROR-gamma
Authors:
Kallen, J.
Deposit date:
2018-12-13
Release date:
2019-11-27
Last modified:
2024-01-24
Method:
X-RAY DIFFRACTION (2.3 Å)
Cite:
Structure-Based and Property-Driven Optimization ofN-Aryl Imidazoles toward Potent and Selective Oral ROR gamma t Inhibitors.
J.Med.Chem., 62, 2019
6Q6M
RORCVAR2 (RORGT, 264-499) IN COMPLEX WITH COMPOUND 1: Identification of N-aryl imidazoles as potent and selective RORgt inhibitors
Descriptor:
Nuclear receptor ROR-gamma, ethyl (2~{S})-2-[(2-chloranyl-6-methyl-phenyl)-thiophen-2-ylcarbonyl-amino]propanoate
Authors:
Kallen, J.
Deposit date:
2018-12-11
Release date:
2019-11-27
Last modified:
2024-01-24
Method:
X-RAY DIFFRACTION (2.35 Å)
Cite:
Structure-Based and Property-Driven Optimization ofN-Aryl Imidazoles toward Potent and Selective Oral ROR gamma t Inhibitors.
J.Med.Chem., 62, 2019
5CY3
SYK catalytic domain complexed with a potent and orally bioavailable benzisothiazole inhibitor
Descriptor:
(5R)-5-[(1R)-1-{[6-(1-methyl-1H-pyrazol-4-yl)-2,1-benzothiazol-4-yl]oxy}ethyl]-1,3-oxazolidin-2-one, Tyrosine-protein kinase SYK
Authors:
Lee, C.C.
Deposit date:
2015-07-30
Release date:
2015-09-23
Last modified:
2024-03-06
Method:
X-RAY DIFFRACTION (1.76 Å)
Cite:
Orally bioavailable Syk inhibitors with activity in a rat PK/PD model.
Bioorg.Med.Chem.Lett., 25, 2015
5CXH
SYK catalytic domain complexed with a potent orally bioavailable thiazole inhibitor
Descriptor:
(4R)-4-[(1R)-1-{[6-(3,4-dimethoxyphenyl)[1,3]thiazolo[5,4-c]pyridin-4-yl]oxy}ethyl]pyrrolidin-2-one, Tyrosine-protein kinase SYK
Authors:
Lee, C.C.
Deposit date:
2015-07-29
Release date:
2015-09-23
Last modified:
2024-03-06
Method:
X-RAY DIFFRACTION (1.9 Å)
Cite:
Orally bioavailable Syk inhibitors with activity in a rat PK/PD model.
Bioorg.Med.Chem.Lett., 25, 2015
<
1
2
홈
톱 페이지
통계정보
도움말
FAQ
문의하기
PDBj인용 / 사용규약
링크
Settings
데이터 등록 (OneDep)
도움말
Deposition to PDB, EMDB or BMRB
다운로드
Download PDB archive / snapshot archive
표준 포맷
PDBx/mmCIF Resources
포맷 변환
PDBx/mmCIF editor
Quick links
도움말
PDB형식 변환불가 엔트리
Group Depositions
Chemical Component entries
Latest entries
검색
도움말
Search PDB (PDBj Mine)
Search PDBj RDB
Chemie search
Search BMRB
Sequence-Navigator
DASH
EM Navigator
Omokage search
Omokage검색
wwPDB/RDF
RDF Portal
Status search
Molecular Viewers
도움말
jV: Graphic Viewer
Molmil: WebGL Mol. Viewer
서비스와 소프트웨어
도움말
Yorodumi
ASH
MAFFTash
NMRToolBox
gmfit
CRNPRED
Spanner
SFAS
HOMCOS
다른 데이터베이스
도움말
eF-site
eF-seek
eF-surf
ProMode Elastic
hGTOP
교재
도움말
eProtS
이달의 분자
Previous workshop
Games
Papermodels
PDBj 정보
도움말
출판물
뉴스레터 / 홍보 리소스
PDBj 회원
PDBj 자문위원회
개인정보 보호방침
223166
건을2024-07-31부터공개중